Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease

被引:94
|
作者
Deva, Djeven Parameshvara [1 ]
Hanneman, Kate [2 ]
Li, Qin [3 ]
Ng, Ming Yen [2 ,6 ]
Wasim, Syed [4 ,5 ,7 ]
Morel, Chantal [4 ,5 ]
Iwanochko, Robert M. [8 ]
Thavendiranathan, Paaladinesh [3 ]
Crean, Andrew Michael [2 ,3 ]
机构
[1] Univ Toronto, St Michaels Hosp, Dept Med Imaging, 30 Bond St, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Dept Med Imaging, Peter Munk Cardiac Ctr, Toronto Gen Hosp, 585 Univ Ave, Toronto, ON M5G 2N2, Canada
[3] Univ Toronto, Peter Munk Cardiac Ctr, Toronto Gen Hosp, Div Cardiol, 585 Univ Ave, Toronto, ON M5G 2N2, Canada
[4] Univ Hlth Network, Fred A Litwin Ctr Genet Med, 60 Murray St,3rd Floor,Room 400, Toronto, ON M5T 3L9, Canada
[5] Mt Sinai Hosp, 60 Murray St,3rd Floor,Room 400, Toronto, ON M5T 3L9, Canada
[6] Univ Hong Kong, Dept Diagnost Radiol, Queen Mary Hosp, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China
[7] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[8] Toronto Western Hosp, Div Cardiol, 399 Bathurst St, Toronto, ON M5T 2S8, Canada
关键词
Cardiomyopathy; Hypertrophy; Cardiovascular magnetic resonance; Anderson-Fabry disease; Left ventricular morphology; Myocardial scar; Late gadolinium enhancement; LEFT-VENTRICULAR HYPERTROPHY; GALACTOSIDASE-A-GENE; ALPHA-GALACTOSIDASE; PAPILLARY-MUSCLES; ATYPICAL VARIANT; SUDDEN-DEATH; CARDIOMYOPATHY; PREVALENCE; MUTATIONS; MANIFESTATIONS;
D O I
10.1186/s12968-016-0233-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although it is known that Anderson-Fabry Disease (AFD) can mimic the morphologic manifestations of hypertrophic cardiomyopathy (HCM) on echocardiography, there is a lack of cardiovascular magnetic resonance (CMR) literature on this. There is limited information in the published literature on the distribution of myocardial fibrosis in patients with AFD, with scar reported principally in the basal inferolateral midwall. Methods: All patients with confirmed AFD undergoing CMR at our center were included. Left ventricular (LV) volumes, wall thicknesses and scar were analyzed offline. Patients were categorized into 4 groups: 1) no wall thickening; 2) concentric hypertrophy; 3) asymmetric septal hypertrophy (ASH); and 4) apical hypertrophy. Charts were reviewed for clinical information. Results: Thirty-nine patients were included (20 males [51 %], median age 45.2 years [range 22.3-64.4]). Almost half (17/39) had concentric wall thickening. Almost half (17/39) had pathologic LV scar; three quarters of these (13/17) had typical inferolateral midwall scar. A quarter (9/39) had both concentric wall thickening and typical inferolateral scar. A subgroup with ASH and apical hypertrophy (n = 5) had greater maximum wall thickness, total LV scar, apical scar and mid-ventricular scar than those with concentric hypertrophy (n = 17, p < 0.05). Patients with elevated LVMI had more overall arrhythmia (p = 0.007) more ventricular arrhythmia (p = 0.007) and sustained ventricular tachycardia (p = 0.008). Conclusions: Concentric thickening and inferolateral mid-myocardial scar are the most common manifestations of AFD, but the spectrum includes cases morphologically identical to apical and ASH subtypes of HCM and these have more apical and mid-ventricular LV scar. Significant LVH is associated with ventricular arrhythmia.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Systolic Myocardial Mechanics in Patients with Anderson-Fabry Disease with and without Left Ventricular Hypertrophy and in Comparison to Nonobstructive Hypertrophic Cardiomyopathy
    Gruner, Christiane
    Verocai, Flavia
    Carasso, Shemy
    Vannan, Mani A.
    Jamorski, Michael
    Clarke, Joe T. R.
    Care, Melanie
    Iwanochko, Robert M.
    Rakowski, Harry
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2012, 29 (07): : 810 - 817
  • [32] Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance
    Pica, Silvia
    Sado, Daniel M.
    Maestrini, Viviana
    Fontana, Marianna
    White, Steven K.
    Treibel, Thomas
    Captur, Gabriella
    Anderson, Sarah
    Piechnik, Stefan K.
    Robson, Matthew D.
    Lachmann, Robin H.
    Murphy, Elaine
    Mehta, Atul
    Hughes, Derralyn
    Kellman, Peter
    Elliott, Perry M.
    Herrey, Anna S.
    Moon, James C.
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2014, 16
  • [33] Segment-by-segment assessment of left ventricular myocardial affection in Anderson-Fabry disease by non-enhanced T1-mapping
    Walter, Thula C.
    Knobloch, Gesine
    Canaan-Kuehl, Sima
    Greiser, Andreas
    Sandek, Anja
    Blaschke, Daniela
    Denecke, Timm
    Hamm, Bernd
    Makowski, Marcus R.
    ACTA RADIOLOGICA, 2017, 58 (08) : 914 - 921
  • [34] Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance
    Jorge A. Torreão
    Barbara M. Ianni
    Charles Mady
    Evandro Naia
    Carlos H. Rassi
    Cesar Nomura
    José R. Parga
    Luis F. Avila
    José A. F. Ramires
    Roberto Kalil-Filho
    Carlos E. Rochitte
    Journal of Cardiovascular Magnetic Resonance, 17
  • [35] Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group
    Imbriaco, Massimo
    Nappi, Carmela
    Ponsiglione, Andrea
    Pisani, Antonio
    Dell'Aversana, Serena
    Nicolai, Emanuele
    Spinelli, Letizia
    Aiello, Marco
    Diomiaiuti, Claudio Tommaso
    Riccio, Eleonora
    Esposito, Roberta
    Galderisi, Maurizio
    Losi, Mariangela
    Greiser, Andreas
    Chow, Kelvin
    Cuocolo, Alberto
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2019, 20 (09) : 1004 - 1011
  • [36] Rapid assessment of myocardial scar and viability in ischemic heart disease: a cardiovascular magnetic resonance study
    Didier Locca
    Chiara Bucciarelli-Ducci
    Jonhatan Lyne
    Marinella Chapparo
    Giuseppe Ferrante
    Rory O'Hanlon
    Sanjay Prasad
    Peter Gatehouse
    Peter Drivas
    Rick Wage
    David Firmin
    Dudley Pennell
    Journal of Cardiovascular Magnetic Resonance, 11 (Suppl 1)
  • [37] Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease
    Tomaz Podlesnikar
    Victoria Delgado
    Jeroen J. Bax
    The International Journal of Cardiovascular Imaging, 2018, 34 : 97 - 112
  • [38] The impact of Wilson disease on myocardial tissue and function: a cardiovascular magnetic resonance study
    Salatzki, Janek
    Mohr, Isabelle
    Heins, Jannick
    Cerci, Mert H.
    Ochs, Andreas
    Paul, Oliver
    Riffel, Johannes
    Andre, Florian
    Hirschberg, Kristof
    Mueller-Hennessen, Matthias
    Giannitsis, Evangelos
    Friedrich, Matthias G.
    Merle, Uta
    Weiss, Karl Heinz
    Katus, Hugo A.
    Ochs, Marco
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2021, 23 (01)
  • [39] A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease
    Kozor, Rebecca
    Callaghan, Fraser
    Tchan, Michel
    Hamilton-Craig, Christian
    Figtree, Gemma A.
    Grieve, Stuart M.
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2015, 17
  • [40] Spectrum and Clinical Significance of Systolic Function and Myocardial Fibrosis Assessed by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
    Olivotto, Iacopo
    Maron, Barry J.
    Appelbaum, Evan
    Harrigan, Caitlin J.
    Salton, Carol
    Gibson, C. Michael
    Udelson, James E.
    O'Donnell, Christopher
    Lesser, John R.
    Manning, Warren J.
    Maron, Martin S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (02) : 261 - 267